.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Teva
Farmers Insurance
AstraZeneca
US Department of Justice
Fuji
Cipla
Express Scripts
Healthtrust
Daiichi Sankyo

Generated: September 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: paliperidone palmitate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Janssen Pharms
INVEGA TRINZA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207946NDAJanssen Pharmaceuticals, Inc50458-606-011 SYRINGE in 1 KIT (50458-606-01) > 1 mL in 1 SYRINGE
Janssen Pharms
INVEGA TRINZA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207946NDAJanssen Pharmaceuticals, Inc50458-607-011 SYRINGE in 1 KIT (50458-607-01) > 1 mL in 1 SYRINGE
Janssen Pharms
INVEGA TRINZA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207946NDAJanssen Pharmaceuticals, Inc50458-608-011 SYRINGE in 1 KIT (50458-608-01) > 1 mL in 1 SYRINGE
Janssen Pharms
INVEGA TRINZA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR207946NDAJanssen Pharmaceuticals, Inc50458-609-011 SYRINGE in 1 KIT (50458-609-01) > 1 mL in 1 SYRINGE
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264NDAJanssen Pharmaceuticals, Inc.50458-560-011 SYRINGE in 1 KIT (50458-560-01) > .25 mL in 1 SYRINGE
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264NDAJanssen Pharmaceuticals, Inc.50458-561-011 SYRINGE in 1 KIT (50458-561-01) > .5 mL in 1 SYRINGE
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264NDAJanssen Pharmaceuticals, Inc.50458-562-011 SYRINGE in 1 KIT (50458-562-01) > .75 mL in 1 SYRINGE
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264NDAJanssen Pharmaceuticals, Inc.50458-563-011 SYRINGE in 1 KIT (50458-563-01) > 1 mL in 1 SYRINGE
Janssen Pharms
INVEGA SUSTENNA
paliperidone palmitate
SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR022264NDAJanssen Pharmaceuticals, Inc.50458-564-011 SYRINGE in 1 KIT (50458-564-01) > 1.5 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Healthtrust
UBS
Accenture
Federal Trade Commission
Citi
Teva
Baxter
Cerilliant
Farmers Insurance

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot